SEC Filing Document

Company: Jones Ventures INTL Acquisition1 Corp
Ticker: 
CIK: 2129056
Filing Type: S-1
Document Type: EX-1.1
Date Filed: 2026-05-15
Accession Number: 0001213900-26-057072
Exchange: 
SIC Code: 6770
SIC Description: Blank Checks
URL: https://www.sec.gov/Archives/edgar/data/2129056/000121390026057072/ea028579202ex1-1.htm

Chunk 8 of 22
Word Count: 1263
Character Count: 8115

Document Content:

other rights that may be issued by the Company substantially in the form filed as an exhibit to the Registration Statement (the “Rights Agreement”). No Existing Non-Competition Agreements. To the Company’s knowledge, no Insider is subject to any non-competition agreement or non-solicitation agreement with any employer or prior employer which could materially affect his ability to be an employee, officer and/or director of the Company, except as disclosed in the Registration Statement. Investments. No more than 45% of the “value” (as defined in Section 2(a)(41) of the Investment Company Act of 1940, as amended (the “Investment Company Act”)) of the Company’s total assets consist of, and no more than 45% of the Company’s net income after taxes is derived from, securities other than “government securities” (as defined in Section 2(a)(16) of the Investment Company Act) or money market funds meeting the conditions of Rule 2a-7 of the Investment Company Act.

Investment Company Act. The Company is not required, and upon the issuance and sale of the Securities as herein contemplated and
the application of the net proceeds therefrom as described in the Sale Preliminary Prospectus and the Prospectus will not be required,
to register as an “investment company” under the Investment Company Act.

Subsidiaries. The Company does not own an interest in any corporation, partnership, limited liability company, joint venture,
trust or other business entity.

Related Party Transactions. No relationship, direct or indirect, exists between or among the Company, on the one hand, and any
Insider, on the other hand, which is required by the Act, the Exchange Act or the Regulations to be described in the Registration Statement,
the Sale Preliminary Prospectus and the Prospectus which is not so described as required. There are no outstanding loans, advances (except
normal advances for business expenses in the ordinary course of business), or guarantees of indebtedness by the Company to or for the
benefit of any of the officers or directors of the Company or any of their respective family members, except as disclosed in the Registration
Statement, the Sale Preliminary Prospectus and the Prospectus. The Company has not extended or maintained credit, arranged for the extension
of credit, or renewed an extension of credit, in the form of a personal loan to or for any director or officer of the Company.

No Influence. The Company has not offered, or caused the Underwriters to offer, the Firm Units to any person or entity with the
intention of unlawfully influencing (a) a customer or supplier of the Company or any affiliate of the Company to alter the customer’s
or supplier’s level or type of business with the Company or such affiliate or (b) a journalist or publication to write or publish
favorable information about the Company or any such affiliate.

Sarbanes-Oxley. The Company is, and on the Closing Date will be, in material compliance with the provisions of the Sarbanes-Oxley
Act of 2002, as amended (“Sarbanes-Oxley”), and the rules and regulations promulgated thereunder and related or similar
rules or regulations promulgated by any governmental or self-regulatory entity or agency, that are applicable to it as of the date hereof.

Distribution of Offering Material by the Company. The Company has not distributed and will not distribute, prior to the later
of the Closing Date and the completion of the distribution of the Public Units and the end of the Market Making Period, any offering
material in connection with the offering and sale of the Public Units other than the Sale Preliminary Prospectus and the Prospectus,
in each case as supplemented and amended.

The Nasdaq Global Market. The Public Units, Public Shares and Public Rights have been authorized for listing, subject to official
notice of issuance and evidence of satisfactory distribution, on the Nasdaq Global Market and the Company knows of no reason or set of
facts that is likely to adversely affect such authorization.

Board of Directors. As of the Effective Date, the Board of Directors of the Company will be comprised of the persons set forth
as “Directors” or “Director nominees” under the heading of the Sale Preliminary Prospectus and the Prospectus
captioned “Management.” As of the Effective Date, the qualifications of the persons serving as board members and the overall
composition of the board will comply with Sarbanes-Oxley and the rules promulgated thereunder and the rules of Nasdaq that are, in each
case, applicable to the Company. As of the commencement of trading of the Units, Public Shares and Public Rights on Nasdaq, the Company
will have an Audit Committee that satisfies the applicable requirements under Sarbanes-Oxley and the rules promulgated thereunder and
the rules of Nasdaq, subject to the permitted phase-in requirements under the rules of Nasdaq.

Emerging Growth Company. From its formation through the date hereof, the Company has been and is an “emerging growth company,”
as defined in Section 2(a) of the Act (an “Emerging Growth Company”).

No Disqualification Events. Neither the Company, nor any of its predecessors or any affiliated issuer, nor any director, executive
officer, or other officer of the Company participating in the Offering, nor any beneficial owner of 20% or more of the Company’s
outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405
under the Act) connected with the Company in any capacity at the Time of Sale (each, a “Company Covered Person” and,
together, “Company Covered Persons”) is subject to any of the “Bad Actor” disqualifications described
in Rule 506(d)(1)(i) to (viii) under the Act (a “Disqualification Event”), except for a Disqualification Event covered
by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Company Covered Person is subject to
a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and
has furnished to the Underwriters a copy of any disclosures provided thereunder.

Free-Writing Prospectus and Testing-the-Waters. The Company has not made any offer relating to the Public Securities that would
constitute an issuer free writing prospectus, as defined in Rule 433 under the Act, or that would otherwise constitute a “free
writing prospectus” as defined in Rule 405 under the Act. The Company: (a) has not engaged in any Testing-the-Waters Communication
other than Testing-the-Waters Communications with the consent of the Representative with entities that are qualified institutional buyers
within the meaning of Rule 144A under the Act or institutions that are accredited investors within the meaning of Rule 501(a) of Regulation
D under the Act and (b) has not authorized anyone to engage in Testing-the-Waters Communications other than its officers and the Representative
and individuals engaged by the Representative. The Company has not distributed any written Testing-the-Waters Communications other than
those listed on Schedule B hereto. “Testing-the-Waters Communication” means any oral or written communication with
potential investors undertaken in reliance on Section 5(d) of the Act.

No Fee Arrangements. Other than the Business Combination Marketing Agreement, the Company has not entered into any agreement,
written or oral, pursuant to which the Company will be obligated to pay any Insider or an affiliate of any Insider a consulting, finder
or success fees for assisting the Company in consummating a Business Combination.

Covenants of the Company. The Company covenants and agrees as follows:

Amendments to Registration Statement. The Company will deliver to the Representative, prior to filing, any amendment or supplement
to the Registration Statement, any Preliminary Prospectus or the Prospectus proposed to be filed after the Effective Date and the Company
shall not file any such amendment or supplement to which the Representative reasonably objects in writing.

Federal Securities Laws.